Clinical & PharmaOmics Consultancy

Clinical & PharmaOmics Consultancy is the translational arm of MultiOmics Intelligence, bridging raw omics data with real-world applications in healthcare, pharma, and public health.

We provide expertise in biomarker discovery, patient stratification, drug response prediction, trial design, and large-scale omics strategy, serving a wide range of partners:

• Clinicians & Hospitals → exploratory biomarker discovery, patient stratification, and molecular interpretation to support precision care.
• Pharma & Biotech → AI-driven biomarker validation, drug response prediction, and translational insights to accelerate drug development and trial design.
• Government & Public Health → population-scale data reanalysis, precision health strategies, and omics workforce training.
• Academic Research Groups → collaborative analysis, grant proposals, and publication-ready outputs.

• Custom Branded Reports → Clear and decision-ready.
• Figures & Visualisations → Publication- and regulatory-friendly.
• Exploratory AI Models → Biomarker signatures and response predictions with interpretability.
• Consultancy Sessions → Expert guidance for your clinical, pharma, or public health project.
•  Implementation Roadmaps → Tailored support for scaling omics into hospitals, pharma pipelines, or government programs.

Our consultancy is disease-agnostic and can be applied to any therapeutic domain, including:

• Oncology & Haematology
• Metabolic & Cardiovascular Disorders
• Neurodegenerative Diseases
• Infectious Diseases
• Rare & Genetic Disorders

•  Omics + AI expertise → from single-cell datasets to national-scale health data.
•  Translational focus → turning raw data into usable insights for clinics and pharma.
•  Academic & industry-ready outputs → reports, dashboards, and publication-ready visuals.
• Safe & compliant → GDPR-compliant handling, framed as research/educational use.
•  Scalable impact → solutions for individual clinicians, institutions, and governments.